The Traderszone Network

Published in TZ Latest News 21 October, 2016 by The TZ Newswire Staff

Advaxis Phase 1/2 Cancer Trial Proceeds (ADXS)

Advaxis launched part B of its ongoing combination Phase 1/2 study of its drug ADXS-PSA to treat late-stage prostrate cancer.